E-LIB Suche - Ergebnisse für: Cerchione, Claudio

1

An overview of prognostic markers in patients with CLL:

Braish, Julie ; Cerchione, Claudio ; Ferrajoli, Alessandra
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Anemia in patients receiving anticancer treatments: focus o..:

Bozzini, Claudia ; Busti, Fabiana ; Marchi, Giacomo...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Targeting DNA2 overcomes metabolic reprogramming in multipl..:

Thongon, Natthakan ; Ma, Feiyang ; Baran, Natalia...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Baseline IgM Amounts Can Identify Patients with Poor Outcom..:

Duminuco, Andrea ; Santuccio, Gabriella ; Chiarenza, Annalisa...
Cancers. 16 (2024) 4 - p. 826 , 2024

Link: https://doi.org/10.3390/..

5

Elotuzumab plus pomalidomide and dexamethasone in relapsed/..:

Martino, Enrica Antonia ; Palmieri, Salvatore ; Galli, Monica...
Hematological Oncology. 42 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

6

Bispecific antibodies for the treatment of relapsed/refract..:

Parrondo, Ricardo D. ; Ailawadhi, Sikander ; Cerchione, Claudio
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

7

Current Therapeutic Sequencing in Chronic Lymphocytic Leuke..:

Mouhssine, Samir ; Maher, Nawar ; Kogila, Sreekar...
Hematology Reports. 16 (2024) 2 - p. 270-282 , 2024

Link: https://doi.org/10.3390/..

8

P883: ALNUCTAMAB (ALNUC; BMS-986349; CC-93269), A BCMA × CD..:

Wong, Sandy W. ; Bar, Noffar ; Victoria Mateos, María...
HemaSphere. 7 (2023) S3 - p. e1220745 , 2023

Link: https://doi.org/10.1097/..

9

How I Manage Chronic Lymphocytic Leukemia:

Nasnas, Patrice ; Cerchione, Claudio ; Musuraca, Gerardo..
Hematology Reports. 15 (2023) 3 - p. 454-464 , 2023

Link: https://doi.org/10.3390/..

10

AVALON: The Italian cohort study on real‐life efficacy of h..:

Todisco, Elisabetta ; Papayannidis, Cristina ; Fracchiolla, Nicola...
Cancer. 129 (2023) 7 - p. 992-1004 , 2023

Link: https://doi.org/10.1002/..

11

POSTER: AML-446 Time to Resolution of Myelosuppression and ..:

Fathi, Amir T. ; Smith, B. Douglas ; Angiolillo, Anne...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S163 , 2023

Link: https://doi.org/10.1016/..

12

Corrigendum: Evaluation of the Stellae-123 prognostic gene ..:

Mosquera Orgueira, Adrián ; Peleteiro Raíndo, Andrés ; Díaz Arias, José Ángel...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

13

P-034 Alnuctamab (ALNUC; BMS-986349; CC-93269), a BCMA × CD..:

Costa, Luciano ; Bar, Noffar ; Mateos, Maria-Victoria...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S52-S53 , 2023

Link: https://doi.org/10.1016/..

14

Management of patients with multiple myeloma and COVID-19 i..:

Terpos, Evangelos ; Musto, Pellegrino ; Engelhardt, Monika...
Leukemia. 37 (2023) 6 - p. 1175-1185 , 2023

Link: https://doi.org/10.1038/..

15

MM-638 Role of the Combination of FDG-PET plus Whole Body M..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S513 , 2023

Link: https://doi.org/10.1016/..